PMID- 25327504 OWN - NLM STAT- MEDLINE DCOM- 20150831 LR - 20221207 IS - 1432-1041 (Electronic) IS - 0031-6970 (Linking) VI - 71 IP - 1 DP - 2015 Jan TI - Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine. PG - 35-41 LID - 10.1007/s00228-014-1764-0 [doi] AB - PURPOSE: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but fatal adverse mucocutaneous reactions to certain drugs. Recent studies suggest that ethnicity and genetic predisposition may play a crucial role in the manifestation of the reaction. In this study, we described the role of human leukocyte antigen (HLA)-B alleles in the development of clinical characteristics and treatment outcomes of SJS/TEN in a single Korean tertiary hospital. METHODS: We retrospectively reviewed the medical records (from March 1, 2010 to February 28, 2014) of 30 patients diagnosed with SJS and/or TEN. RESULTS: The main causative drugs were anticonvulsants (26.7 %) and allopurinol (26.7 %), followed by antibiotics (16.7 %), acetazolamide (10.0 %), acetaminophen (10.0 %), and herbal medication (6.7 %). The mean latencies of these drugs were variable. Liver damage was the most common symptom (observed in 63.3 % of the patients). Of the five patients with lamotrigine-induced SJS/TEN, three expressed the HLA-B*4403 allele (60.0 %). Of the seven patients with allopurinol-induced SJS/TEN, five expressed the HLA-B*5801 allele (71.4 %). CONCLUSIONS: The major SJS/TEN-inducing drugs were found to be allopurinol and anticonvulsants (such as lamotrigine). We speculated that Korean individuals expressing the HLA-B*4403 allele may be highly susceptible to lamotrigine-induced SJS/TEN. FAU - Park, Hye Jung AU - Park HJ AD - Division of Allergy and Immunology, Department of Internal Medicine, Institute of Allergy, Yonsei University College of Medicine, Seoul, South Korea. FAU - Kim, Sung Ryeol AU - Kim SR FAU - Leem, Dong Woo AU - Leem DW FAU - Moon, Il Joo AU - Moon IJ FAU - Koh, Beom Seok AU - Koh BS FAU - Park, Kyung Hee AU - Park KH FAU - Park, Jung-Won AU - Park JW FAU - Lee, Jae-Hyun AU - Lee JH LA - eng PT - Journal Article DEP - 20141021 PL - Germany TA - Eur J Clin Pharmacol JT - European journal of clinical pharmacology JID - 1256165 RN - 0 (Anti-Bacterial Agents) RN - 0 (Anticonvulsants) RN - 0 (HLA-B Antigens) RN - 0 (Triazines) RN - 362O9ITL9D (Acetaminophen) RN - 63CZ7GJN5I (Allopurinol) RN - O3FX965V0I (Acetazolamide) RN - U3H27498KS (Lamotrigine) SB - IM MH - Acetaminophen/adverse effects MH - Acetazolamide/adverse effects MH - Adult MH - Aged MH - Aged, 80 and over MH - Alleles MH - Allopurinol/adverse effects MH - Anti-Bacterial Agents/adverse effects MH - Anticonvulsants/*adverse effects MH - Asian People/*genetics MH - Female MH - *Genetic Predisposition to Disease MH - HLA-B Antigens/*genetics MH - Humans MH - Lamotrigine MH - Male MH - Middle Aged MH - Plants, Medicinal/adverse effects MH - Republic of Korea MH - Stevens-Johnson Syndrome/etiology/*genetics MH - Tertiary Care Centers MH - Triazines/*adverse effects MH - Young Adult EDAT- 2014/10/21 06:00 MHDA- 2015/09/01 06:00 CRDT- 2014/10/21 06:00 PHST- 2014/04/16 00:00 [received] PHST- 2014/09/29 00:00 [accepted] PHST- 2014/10/21 06:00 [entrez] PHST- 2014/10/21 06:00 [pubmed] PHST- 2015/09/01 06:00 [medline] AID - 10.1007/s00228-014-1764-0 [doi] PST - ppublish SO - Eur J Clin Pharmacol. 2015 Jan;71(1):35-41. doi: 10.1007/s00228-014-1764-0. Epub 2014 Oct 21.